tiprankstipranks
Trending News
More News >
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
US Market

Gyre Therapeutics (GYRE) Cash flow

Compare
821 Followers

Gyre Therapeutics Cash Flow

GYRE's free cash flow for Q3 2025 was $3.99M. For the 2025 fiscal year, GYRE's free cash flow was decreased by $-24.07M and operating cash flow was $4.68M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -3.64M$ 25.89M$ 10.68M$ -83.75M$ -55.05M
Investing Cash Flow
$ -19.88M$ -19.76M$ -13.81M$ 48.19M$ 9.66M
Financing Cash Flow
$ 2.10M$ 2.50M$ 0.00$ 49.55M$ 60.38M
End Cash Position
$ 11.81M$ 33.51M$ 25.18M$ 44.35M$ 30.36M
Free Cash Flow
$ -6.77M$ 17.31M$ 5.68M$ -84.59M$ -55.31M
Currency in USD

Gyre Therapeutics Cash Flow